Skip to main content
Diagnostic Medical Systems logo

Diagnostic Medical Systems — Investor Relations & Filings

Ticker · ALDMS ISIN · FR0012202497 LEI · 969500RKTIGCNNIKIN19 PA Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country FR France
Listing PA ALDMS

About Diagnostic Medical Systems

https://www.dms.com/en/home/

Diagnostic Medical Systems (DMS) specializes in the development, design, and manufacturing of medical imaging systems. The company's core focus is on digital radiology and bone densitometry. Its product portfolio includes radiography and fluoroscopy systems, mobile x-ray units, surgical C-arms, and bone densitometers. DMS is engaged in developing next-generation imaging solutions aimed at improving patient care and personalized medicine. Key development projects include new mobile and surgical imaging equipment and an advanced range of bone densitometers for diagnosing and monitoring pathologies affecting bone mineral density.

Recent filings

Filing Released Lang Actions
Information relative au nombre total de droits de vote et d'actions composant le capital au 31 mai 2026
Regulatory Filings Classification · 85% confidence The document is a regulatory announcement under French commercial code L.225-73-1 disclosing the total number of voting rights and shares composing the company’s capital as of May 31, 2026. It does not announce a specific report being published, nor is it an insider transaction, earnings release, or an AGM material. It is a routine regulatory disclosure that does not fit a more specific category, so it falls into Regulatory Filings (RNS).
2026-06-03 French
DMS GROUP RECEIVES EUR 4 MILLION FROM THE EUROPEAN INVESTMENT BANK, 1ST DRAWDOWN OF THE TOTAL FINANCING OF EUR 20 MILLION
Capital/Financing Update Classification · 90% confidence The document is a press release announcing the drawdown of financing (€4 million) from the European Investment Bank, details of the total €20 million financing line, interest terms, issuance of share subscription warrants, and impact on share capital. It is a clear update on the company’s financing activities and capital structure, rather than a full financial report, AGM materials, or earnings release.
2026-06-01 English
DMS GROUP REÇOIT 4 M EUR DE LA BANQUE EUROPÉENNE D'INVESTISSEMENT, 1ER VERSEMENT DU FINANCEMENT TOTAL DE 20 M EUR
Capital/Financing Update Classification · 91% confidence The document is a press release announcing the drawdown of the first €4 million tranche of a €20 million financing facility from the European Investment Bank, describes the terms of the loan, issuance of subscription warrants (BSA), and capital structure implications. It is not a full financial report or meeting materials, but rather a financing update. Hence it fits Capital/Financing Update (CAP).
2026-06-01 French
Information relative au nombre total de droits de vote et d'actions composant le capital au 30 avril 2026 - ERRATUM
Major Shareholding Notification Classification · 95% confidence The document is a short announcement dated May 7, 2026, regarding the total number of voting rights and shares composing the capital of DMS Group as of April 30, 2026. It corrects a previous press release with an erratum about voting rights. The content focuses on share capital and voting rights information, with no financial statements or detailed financial data. The document length is 1767 characters, which is quite short and fits the profile of a notification rather than a full report. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes or clarifications in significant share ownership or voting rights levels. It is not an Annual Report, Interim Report, or any other detailed financial or management report. Therefore, the correct classification is MRQ with high confidence.
2026-05-07 French
Information relative au nombre total de droits de vote et d'actions composant le capital au 30 avril 2026
Major Shareholding Notification Classification · 95% confidence The document is dated May 5, 2026, and provides information about the total number of voting rights and shares composing the capital as of April 30, 2026. It references compliance with article L. 225-73-1 of the French commercial code, which relates to disclosure of voting rights and share capital. The content is a formal announcement of the number of shares and voting rights, not a full financial report or detailed analysis. The document length is short (1659 characters), and it does not contain financial statements or management discussion. It is not an annual or interim report, nor a call transcript or earnings release. It is a regulatory announcement about share capital and voting rights. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes or disclosures about significant share ownership or voting rights levels.
2026-05-05 French
Q1 2026 REVENUE: EUR 10 MILLION
Earnings Release Classification · 85% confidence The document is a press release announcing the company’s consolidated revenue for the 1st quarter of fiscal 2026, providing key highlights, quarter-on-quarter comparisons, brief commentary on business segments, geographic developments, and outlook. It is a standard quarterly earnings announcement rather than a full interim report or detailed financial statements. Therefore it fits the Earnings Release category. Q1 2026
2026-04-21 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.